Rob75, RE: NXXI
Date 2007-10-02
"Nutrition 21 reported fiscal Q4 (June 30) revenues of $12 million, a 380% jump over the year-ago number. For the fiscal year, NXXI reported total revenues of $42.1 million compared to $10.7 million last year. Net loss for fiscal year 2007 was $19.1 million, compared to a net loss of $10.3 million in 2006.
Nutrition 21 has grown revenues in each of the last four quarters, excluding a one-time charge in the fourth quarter. And with the investments made during this past year and the recent $17.75 million financing, NXXI is in the strongest position it's ever been to build its brands and to generate sustainable growth in 2008 and beyond.
Bottom Line: Nutrition 21 begins fiscal 2008 with a clean slate, having transitioned from an R&D-focused company to a marketing-driven one selling branded consumer products targeted at diabetes, cardiovascular health, obesity, joint health and other age-related ailments.
At less than $1, NXXI is a very attractive buy. We're looking for the company to transform to profitability in the second half of 2008."
NXXI is currently sitting at its 52 week low.
regards,
gktignol
News 
Market Data 
Discover 
AI
